Stage IIIB Breast Cancer AJCC v7 Recruiting Phase 3 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03199885Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerTreatment